SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001123292-21-000068
Filing Date
2021-01-11
Accepted
2021-01-11 17:27:43
Documents
1
Group Members
EDWARD A. MULEROBERT J. O'SHEA

Document Format Files

Seq Description Document Type Size
1 pdl13d_01042021.htm SC 13D 121920
  Complete submission text file 0001123292-21-000068.txt   123606
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-43256 | Film No.: 21521719
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Filed by) CIK: 0001332784 (see all company filings)

IRS No.: 223844936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D